Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Impact of CAD-deficiency in flax on biogas production.

Wróbel-Kwiatkowska M, Jabłoński S, Szperlik J, Dymińska L, Łukaszewicz M, Rymowicz W, Hanuza J, Szopa J.

Transgenic Res. 2015 Jul 16. [Epub ahead of print]

PMID:
26178244
2.

Natural phenolics greatly increase flax (Linum usitatissimum) oil stability.

Hasiewicz-Derkacz K, Kulma A, Czuj T, Prescha A, Żuk M, Grajzer M, Łukaszewicz M, Szopa J.

BMC Biotechnol. 2015 Jun 30;15(1):62. doi: 10.1186/s12896-015-0178-0.

3.

Effect of Dose and Administration Period of Seed Cake of Genetically Modified and Non-Modified Flax on Selected Antioxidative Activities in Rats.

Matusiewicz M, Kosieradzka I, Zuk M, Szopa J.

Int J Mol Sci. 2015 Jun 23;16(6):14259-75. doi: 10.3390/ijms160614259.

4.

Polyamine metabolism in flax in response to treatment with pathogenic and non-pathogenic Fusarium strains.

Wojtasik W, Kulma A, Namysł K, Preisner M, Szopa J.

Front Plant Sci. 2015 Apr 29;6:291. doi: 10.3389/fpls.2015.00291. eCollection 2015.

5.

Effects of hatha yoga exercises on spine flexibility in women over 50 years old.

Grabara M, Szopa J.

J Phys Ther Sci. 2015 Feb;27(2):361-5. doi: 10.1589/jpts.27.361. Epub 2015 Feb 17.

6.
7.

Oligonucleotide treatment causes flax β-glucanase up-regulation via changes in gene-body methylation.

Wojtasik W, Kulma A, Boba A, Szopa J.

BMC Plant Biol. 2014 Oct 5;14:261. doi: 10.1186/s12870-014-0261-z.

8.

Genetically modified flax expressing NAP-SsGT1 transgene: examination of anti-inflammatory action.

Matusiewicz M, Kosieradzka I, Zuk M, Szopa J.

Int J Mol Sci. 2014 Sep 22;15(9):16741-59. doi: 10.3390/ijms150916741.

9.

Does biopolymers composition in seeds contribute to the flax resistance against the Fusarium infection?

Zeitoun AM, Preisner M, Kulma A, Dymińska L, Hanuza J, Starzycki M, Szopa J.

Biotechnol Prog. 2014 Sep-Oct;30(5):992-1004. doi: 10.1002/btpr.1965. Epub 2014 Aug 8.

PMID:
25080398
10.

Bactericidal activities of GM flax seedcake extract on pathogenic bacteria clinical strains.

Zuk M, Dorotkiewicz-Jach A, Drulis-Kawa Z, Arendt M, Kulma A, Szopa J.

BMC Biotechnol. 2014 Jul 29;14:70. doi: 10.1186/1472-6750-14-70.

11.

Manipulating cinnamyl alcohol dehydrogenase (CAD) expression in flax affects fibre composition and properties.

Preisner M, Kulma A, Zebrowski J, Dymińska L, Hanuza J, Arendt M, Starzycki M, Szopa J.

BMC Plant Biol. 2014 Feb 20;14:50. doi: 10.1186/1471-2229-14-50.

12.

Transgenic potato plants with overexpression of dihydroflavonol reductase can serve as efficient nutrition sources.

Kostyn K, Szatkowski M, Kulma A, Kosieradzka I, Szopa J.

J Agric Food Chem. 2013 Jul 10;61(27):6743-53. doi: 10.1021/jf400645s. Epub 2013 Jun 26.

PMID:
23692339
13.

Indices of insulin resistance and dyslipidemia are correlated with lymphocyte proneness to apoptosis in obese or overweight low birth weight children.

Barg E, Szopa J, Pesz KA, Gąsiorowski K.

Horm Res Paediatr. 2013;79(5):293-9. doi: 10.1159/000351012. Epub 2013 May 15.

PMID:
23689125
14.

Fibres from flax overproducing β-1,3-glucanase show increased accumulation of pectin and phenolics and thus higher antioxidant capacity.

Wojtasik W, Kulma A, Dymińska L, Hanuza J, Żebrowski J, Szopa J.

BMC Biotechnol. 2013 Feb 9;13:10. doi: 10.1186/1472-6750-13-10.

15.

Improved properties of micronized genetically modified flax fibers.

Dymińska L, Szatkowski M, Wróbel-Kwiatkowska M, Zuk M, Kurzawa A, Syska W, Gągor A, Zawadzki M, Ptak M, Mączka M, Hanuza J, Szopa J.

J Biotechnol. 2012 Dec 15;164(2):292-9. doi: 10.1016/j.jbiotec.2013.01.002. Epub 2013 Jan 24.

PMID:
23353730
16.

The response of diabetic foot to a new type of dressing.

Skórkowska-Telichowska K, Kulma A, Szopa J.

Int Arch Med. 2012 Dec 18;5(1):33. doi: 10.1186/1755-7682-5-33.

17.

The biomedical potential of genetically modified flax seeds overexpressing the glucosyltransferase gene.

Czemplik M, Kulma A, Bazela K, Szopa J.

BMC Complement Altern Med. 2012 Dec 10;12:251. doi: 10.1186/1472-6882-12-251.

18.

New biocomposites based on bioplastic flax fibers and biodegradable polymers.

Wróbel-Kwiatkowska M, Czemplik M, Kulma A, Zuk M, Kaczmar J, Dymińska L, Hanuza J, Ptak M, Szopa J.

Biotechnol Prog. 2012 Sep-Oct;28(5):1336-46. doi: 10.1002/btpr.1599. Epub 2012 Aug 17.

PMID:
22807200
19.

Cannabinoid-like anti-inflammatory compounds from flax fiber.

Styrczewska M, Kulma A, Ratajczak K, Amarowicz R, Szopa J.

Cell Mol Biol Lett. 2012 Sep;17(3):479-99. doi: 10.2478/s11658-012-0023-6. Epub 2012 Jun 13.

PMID:
22706678
20.

Flax terpenoid pathway as a source of health promoting compounds.

Styrczewska M, Kulma A, Kostyn K, Hasiewicz-Derkacz K, Szopa J.

Mini Rev Med Chem. 2013 Mar;13(3):353-64. Review.

PMID:
22625416
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk